Farms.com Home   News

Saskatchewan SPCA opposes strychnine use: "Secondary poisoning is a big concern"

The Saskatchewan SPCA is against an emergency registration for liquid strychnine to control a growing gopher population in Saskatchewan and Alberta.

Health Canada's Pesticides Regulatory Directorate, formerly known as the Pest Management Regulatory Agency, approved its use in late-March with multiple conditions attached to ensure safe use on the population of Richardson's ground squirrels.

"We definitely understand that farmers do need to control these populations, and we sympathize with them, but we also need to be aware of the risks that putting poison in the environment can have, especially as secondary poisoning is a big concern." said Mikayla Basset, Education Coordinator with the SPCA.

"Secondary poisoning is when an animal eats a baited ground squirrel. A ground squirrel that has been poisoned dies and then gets eaten by a predator, and that predator then gets poisoned and dies itself. So the spread through the food web is very concerning for us and can cause very damaging ecological risks."

Strychnine can cause severe muscle spasms, seizures, and respiratory failure within a short period of time, leading to significant suffering, says the SPCA in a news release.

They cite a 2020 re-valuation from the former PMRA that concluded "the environmental risks of strychnine use for Richardson’s ground squirrel control were unacceptable, particularly due to the threat posed to non-target wildlife, including species at risk. Research has shown that poisoned carcasses can remain accessible on the surface and that mitigation measures do not reliably prevent exposure to other animals."

The SPCA also say gophers play a key role in the prairie ecosystem, primarily being a key food source for a variety of natural predators, along with "contributing to soil aeration, water infiltration," and nutrient cycling.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.